NCT01854021

Brief Summary

Surgical excision is the mainstay of treatment for tongue cancer. However, surgery-induced immunosuppression has been implicated in the development of post-operative septic complications and neoplasm metastasis. General anesthesia is considered to not only suppress surgical stress, but also affect the immune function directly,such as altering the number and activity of immune cells. It is reported that some anesthetics increase susceptibility to tumor metastasis, apparently by suppressing natural killer cell activity. Different anesthetic techniques and anesthetics used in anesthesia have shown different effects on immunity. Many of the studies were animal trials or performed in vitro; in addition, most are focused on a single drug. To date, there is little published prospective clinical research designed specifically to investigate the effects of different general anesthetic technique on immune function in patients with oral malignant tumors. The aim of this study is going to characterize the immune response of patients undergoing surgery for tongue cancer under 3 types of general anesthesia.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2013

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

May 7, 2013

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 15, 2013

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2013

Completed
Last Updated

May 17, 2013

Status Verified

May 1, 2013

Enrollment Period

3 months

First QC Date

May 7, 2013

Last Update Submit

May 16, 2013

Conditions

Keywords

AnesthesiageneralImmunityTongue neoplasmsimmunegeneral anesthesia

Outcome Measures

Primary Outcomes (1)

  • Percentages of immune cells

    30 min before induction, 1 h, 3 h and 5 h after induction; at the end of operation and 24h, 48 h and 72 h after operation

    3 days

Secondary Outcomes (3)

  • Percentages of T lymphocytes subsets

    3 days

  • Percentages of Natural Killer cells

    3 days

  • Percentages of B lymphocytes

    3 days

Study Arms (3)

inhalational anesthesia

EXPERIMENTAL

inhalational anesthesia

Procedure: inhalational anesthesia

combined intravenous-inhalational anesthesia

EXPERIMENTAL

combined intravenous-inhalational anesthesia

Procedure: combined intravenous-inhalational anesthesia

intravenous anesthesia

EXPERIMENTAL

intravenous anesthesia

Procedure: intravenous anesthesia

Interventions

intravenous anesthesia

intravenous anesthesia

combined intravenous-inhalational anesthesia

combined intravenous-inhalational anesthesia

inhalational anesthesia

inhalational anesthesia

Eligibility Criteria

Age50 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • All the patients were scheduled for elective surgery for tongue cancer under general anesthesia. None of the patients had a history of endocrine, immune and circulatory system diseases;

You may not qualify if:

  • contraindications for receiving chemotherapy,
  • receiving perioperative blood transfusion, or
  • preoperative and perioperative treatment with hormones and immunomodulatory agent.
  • Patients who suffered from any surgical complications such as infection were also excluded from our study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital of stomatology of wuhan university

Wuhan, Hubei, 430079, China

RECRUITING

MeSH Terms

Conditions

Tongue Neoplasms

Interventions

Anesthesia, Intravenous

Condition Hierarchy (Ancestors)

Mouth NeoplasmsHead and Neck NeoplasmsNeoplasms by SiteNeoplasmsMouth DiseasesStomatognathic DiseasesTongue Diseases

Intervention Hierarchy (Ancestors)

AnesthesiaAnesthesia and Analgesia

Study Officials

  • kebin Liu

    Master of Department of Anesthesiology of Hospital of Stomatology, Wuhan University

    STUDY DIRECTOR

Central Study Contacts

tiejun zhang, M.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Department of Anesthesiology , School and Hospital of Stomatology, Wuhan University

Study Record Dates

First Submitted

May 7, 2013

First Posted

May 15, 2013

Study Start

May 1, 2013

Primary Completion

August 1, 2013

Last Updated

May 17, 2013

Record last verified: 2013-05

Locations